Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies

Nanotoxicology

Volumn 1, Issue 1, 2007, Pages 42-51

  Powers, Kevin W ^a   Palazuelos, Maria ^a,b   Moudgil, Brij M ^a   Roberts, Stephen M ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b University of Florida   (United States)

Author keywords

Characterization; Dispersion; Nanoparticles; Shape; Size; Toxicity

Indexed keywords

NANOMATERIAL; NANOPARTICLE;

ANALYTIC METHOD; CELL FUNCTION; CHEMICAL STRUCTURE; DISPERSION; DRY POWDER; ENVIRONMENT; LABORATORY TEST; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; STANDARD; SURFACE PROPERTY; TOXICITY TESTING; TOXICOLOGY;

EID: 34147191540     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.1080/17435390701314902     Document Type: Review

References (31)

1. Allen T. 2004a. Particle size measurement, Vol I: Powder sampling and particle size measurement. 5th ed. London: Chapman & Hall.
2. Allen T. 2004b. Particle size measurement, Vol II: Surface area and pore size determination. 5th ed. London: Chapman & Hall.
3. Berry CC, Dalby MJ, McCloy D, Affrossman S. 2005. The fibroblast response to tubes exhibiting internal nanotopography. Biomaterials 26:4985-4892.
4. Borm PJA, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, Schins R, Stone V, Kreyling W, Lademann J, Krutmann J, Warheit D, Oberdörster E. 2006. The potential risks of nanomaterials: A review carried out for ECETOC. Particle Fibre Toxicol 3:11-46.
5. Bucher J, Masten S, Moudgil B, Powers K, Roberts S, Walker N. 2004. Developing experimental approaches for the evaluation of toxicological interactions of nanoscale materials. Final workshop report 3-4 November 2004, University of Florida, Gainesville, FL USA. www.nanotoxicology.ufl.edu.
6. Castranova V. 2000. From coal mine dust to quartz: Mechanisms of pulmonary pathogenicity. Inhalation Tox 12:7-14.
7. Gutwein L, Webster T. 2002. Osteoblast and chrondrocyte proliferation in the presence of alumina and titania nanoparticles. J Nanoparticle Res 4:231-238.
8. Hart GA, Hesterberg TW. 1998. In vitro toxicity of respirable-size particles of diatomaceous earth, and crystalline silica compared with asbestos and titanium dioxide. J Occup Environ Med 40:29-42.
9. Hentschel M, Page N. 2003. Selection of descriptors for particle shape characterization. Particle Particle Sys Char 20:25-38.
10. Heyder J. 2004. Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery. Proc Amer Thoracic Soc 1:315-320.
11. Hinds WC. 1999. Aerosol technology: Properties, behavior, and measurement of airborne particles. New York: Wiley.
12. International Commission on Radiological Protection (ICRP). 1994. Human respiratory tract models for radiological protection. Ann ICRP 24.
13. Jillavenkatesa A, Kelly J. 2002. Nanopowder characterization: challenges and future directions. J Nanopart Res 4:463-468.
14. Kammler H, Mädler L, Pratsinis S. 2001. Flame synthesis of nanoparticles. Chem Engineer Tech 24:583-596.
15. Knapp J, Barber T, Lieberman A, editors. 1996. Liquid-and surface-borne particle measurement handbook. New York: Marcel Dekker Ltd.
16. Lucarelli M, Gatti A, Sararino G, Quattroni P, Marinelli L, Monari E, Boraschi D. 2004. Innate defence functions of macrophages can be biased by nano-size ceramic and metallic particles. Eur Cytokine Netw 15:339-346.
17. Masuda H, Inoya K. 1971. Theoretical study of the scatter of experimental data due to particle size distribution. J Chem Engineer Japan 4:60-67.
18. Masuda H, Higashitani KD, Yoshida H. 2006. Powder technology handbook. Boca Raton: Taylor & Francis.
19. Mossman BT, Churg A. 1998. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Resp Crit Care Med 157:1666-1680.
20. National Institute for Occupational Safety and Health (NIOSH). 1994. Manual of Analytical Methods (NMAM®). Cincinnati, Ohio.
21. National Institute of Standards and Technology (NIST). 2001. Practice Guide SP 960-1, Jillavenkatesa A, Dapkunas S, and Lum H. Particle Size Characterization.
22. National Research Council (NRC). 1989. Biologic Markers in Pulmonary Toxicology, Subcommittee on Pulmonary Toxicology Committee on Biologic Markers. Washington, DC: National Academy Press.
23. Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, et al. 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8-43.
24. Office of Environmental Information: 40 CFR 799.9346: Subpart H-Health Effects Test Guidelines, TSCA 90-Day Inhalation Toxicity Term Detal Available: http://iaspub.epa.gov/trs/trs_proc_qry.org_info?P_REG_AUTH_ID= 1044&p_list_option_cd=ORG via the INTERNET. Accessed 2007 Jan 30.
25. Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM. 2006. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Tox Sci 90:296-303.
26. Renwick LC, Donaldson K, Clouter A. 2001. Impairment of alveolar macrophage phagocytosis by ultrafine particles. Toxicol Appl Pharmacol 172:119-127.
27. Roco MC. 2001. International strategy for nanotechnology research and development. J Nanoparticle Res 3:353-360.
28. Royal Society. 2004. Nanoscience and nanotechnologies: opportunities and uncertainties, RS Policy Document 19/04.
29. Thomas K, Sayre P. 2005. Research strategies for safety evaluation of nanomaterials, Part I: Evaluating the human health implications of exposure to nanoscale materials. Tox Sci 87:316-321.
30. Weiss R. 2004. For science, nanotech poses big unknowns. 1 February 2004. Washington, DC: Washington Post.
31. Zhang Z, Kleinstreuer C, Donohue JF, Kim CS. 2005. Comparison of micro- and nano-size particle depositions in a human upper airway model. J Aerosol Sci 36:211-233.